146 related articles for article (PubMed ID: 1717649)
1. D1 dopamine receptors of NS20Y neuroblastoma cells are functionally similar to rat striatal D1 receptors.
Lovenberg TW; Roth RH; Nichols DE; Mailman RB
J Neurochem; 1991 Nov; 57(5):1563-9. PubMed ID: 1717649
[TBL] [Abstract][Full Text] [Related]
2. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors.
Lovenberg TW; Nichols DE; Nestler EJ; Roth RH; Mailman RB
Brain Res; 1991 Aug; 556(1):101-7. PubMed ID: 1682005
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
Barton AC; Sibley DR
Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
[TBL] [Abstract][Full Text] [Related]
4. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
5. Activation of postsynaptic striatal dopamine receptors, monitored by efflux of cAMP in vivo.
Hutson PH; Suman-Chauhan N
Neuropharmacology; 1990 Nov; 29(11):1011-6. PubMed ID: 1982337
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
7. M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.
Sánchez-Lemus E; Arias-Montaño JA
Neurochem Res; 2006 Apr; 31(4):555-61. PubMed ID: 16758365
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.
Black LE; Smyk-Randall EM; Sibley DR
Mol Cell Neurosci; 1994 Dec; 5(6):567-75. PubMed ID: 7704430
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
[TBL] [Abstract][Full Text] [Related]
11. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
Battaglia G; Norman AB; Hess EJ; Creese I
J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
13. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
[TBL] [Abstract][Full Text] [Related]
14. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
[TBL] [Abstract][Full Text] [Related]
15. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
16. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
17. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
18. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
Undie AS; Friedman E
J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756
[TBL] [Abstract][Full Text] [Related]
20. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
Hess EJ; Battaglia G; Norman AB; Creese I
Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
